← Eichor
Study identifier: NCT07382440 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

Condition: Parkinson's Disease  ·  Sponsor: AbbVie

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective Foslevodopa/Foscarbidopa is in treating adult participants with advanced Parkinson Disease under routine clinical practice in Belgium. Foslevodopa/Foscarbidopa is an approved drug for the treatment of Parkinson's Disease. Approximately 120 adult participants who are prescribed Foslevodopa/Foscarbidopa by their doctors will be enrolled at 15 sites across Belgium. Participants will receive Foslevodopa/Foscarbidopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 18 months. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Clementine Semanaz  ·  844-663-3742  ·  clementine.semanaz@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (12)

Imelda Ziekenhuis /ID# 279436Bonheiden, Antwerpen, BelgiumRecruiting
Universitair Ziekenhuis Antwerpen /ID# 279434Edegem, Antwerpen, BelgiumRecruiting
Chu Tivoli /ID# 279455La Louvière, Hainaut, BelgiumRecruiting
Centre Hospitalier De Wallonie Picarde - Site Notre Dame /ID# 279452Tournai, Hainaut, BelgiumRecruiting
Jessa Ziekenhuis - Campus Virga Jesse /ID# 279454Hasselt, Limburg, BelgiumRecruiting
AZ Sint-Lucas /ID# 279453Ghent, Oost-Vlaanderen, BelgiumRecruiting
UZ Gent /ID# 279433Ghent, Oost-Vlaanderen, BelgiumRecruiting
Universitair Ziekenhuis Leuven /ID# 279439Leuven, Vlaams-Brabant, BelgiumRecruiting
Algemeen Ziekenhuis Sint-Jan Brugge /ID# 279422Bruges, West-Vlaanderen, BelgiumRecruiting
Az Groeninge Campus Kennedylaan /ID# 279423Kortrijk, West-Vlaanderen, BelgiumRecruiting
AZ Oostende /ID# 279461Ostend, West-Vlaanderen, BelgiumRecruiting
AZ-Delta. /ID# 279437Roeselare, West-Vlaanderen, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07382440